Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 30,769 |
|
|||||
| News | - | ||||||
| Day High | 1.1654 | Low High |
|||||
| Day Low | 1.11 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CERo Therapeutics Holdings Inc | CERO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0139 | -1.20% | 1.14 | 16:56:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.14 | 1.11 | 1.1654 | 1.13 | 1.1539 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 292 | 30,769 | $ 1.13 | $ 34,865 | - | 1.10 - 12.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:45:19 | 15 | $ 1.16 | USD |
CERo Therapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 16.78M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CERo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CERO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.21 | 1.2605 | 1.10 | 1.15 | 60,497 | -0.07 | -5.79% |
| 1 Month | 1.70 | 1.7201 | 1.10 | 1.37 | 107,377 | -0.56 | -32.94% |
| 3 Months | 3.42 | 10.95 | 1.10 | 3.05 | 1,159,702 | -2.28 | -66.67% |
| 6 Months | 5.25 | 12.38 | 1.10 | 3.06 | 1,091,794 | -4.11 | -78.29% |
| 1 Year | 5.25 | 12.38 | 1.10 | 3.06 | 1,091,794 | -4.11 | -78.29% |
| 3 Years | 5.25 | 12.38 | 1.10 | 3.06 | 1,091,794 | -4.11 | -78.29% |
| 5 Years | 5.25 | 12.38 | 1.10 | 3.06 | 1,091,794 | -4.11 | -78.29% |
CERo Therapeutics Description
| CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company¿s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body¿s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies. |
